Deal targets treatment-resistant depression market as Lilly diversifies beyond its dominant GLP-1 drug portfolio. Eli Lilly (LLY) agreed to acquire clinical-stage biotech AtaiBeckley for $2.8 billion in cash, bolstering its neuroscience business. The deal includes BPL-003,
Company aims to separate lubricants business within 12-18 months while adjusting leadership and refining capacity goals. HF Sinclair announced plans to separate its lubricants business within 12-18 months, targeting refining runs of 590,000-620,000 barrels per day in Q3 20
The medtech firm targets $500m in annual pre-tax savings by 2029 through supply chain and organizational changes. Boston Scientific will launch a global restructuring program costing $700m to $800m, aiming to reduce annual pre-tax expenses by $500m by 2029. The plan includ
Mercedes-Benz reports a 26% drop in Q2 adjusted EBIT to 909 million euros as China demand softens, while US lawmakers advance a bill targeting Chinese-linked automakers. Mercedes-Benz posted a 26% year-over-year decline in second-quarter adjusted EBIT to 909 million euros,
Apple’s $100B buyback and 4% dividend hike contrast with Nvidia’s 92% data-center reliance and thinner payout history. Apple reclaimed the world’s largest market cap at $337.47 per share, surpassing Nvidia’s $196.03, after announcing a 4% dividend increase to $0.27 per qua
Is the sell-off finally over for Space Exploration Technologies (NASDAQ: SPCX) stock? Shares of Elon Musk's famed space enterprise fell to $107 a share this morning, a near-6% drop that prompted Bloomberg to crow that SpaceX stock had fallen 20% and erased "$1.2 trillion"
Starbucks reports third-quarter results after market close on July 29, with revenue expected at $9.12B amid turnaround efforts. Starbucks (SBUX) will release its third-quarter earnings on July 29, with options markets pricing in a 5.51% stock movement post-report. Investor
The display maker offset revenue declines with lower warranty expenses and operational efficiencies in the first quarter. Daktronics reported a first-quarter profit improvement despite lower revenues, driven by a $2 million reduction in warranty costs compared to both the
Incyte forecasts $5.130B-$5.260B 2026 net sales Incyte Corporation has raised its guidance for Opzelura sales to $1.050B-$1.1B. The company's net sales forecast for 2026 is $5.130B-$5.260B. Incyte's CEO stated that the company is moving from reliance on a c
Bank of N.T. Butterfield expects the deal to close in H1 2027, expanding its regional footprint and asset base significantly. Bank of N.T. Butterfield & Son Limited outlined plans to acquire CIBC Caribbean, projecting combined assets of approximately $29 billion. The trans
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.